Physician profile
James B Jackson
NPI 1912165234
$10,151.49
in general payments reported to CMS, 2019-2025
11 companies · $7,846 in 2025
The $7,846 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $679 · 2022: $1,296 · 2023: $205 · 2024: $125 · 2025: $7,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,001 · Travel and Lodging: $1,508 · Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.50 |
| Travel and Lodging | $1,507.80 |
| Food and Beverage | $667.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vilex LLC | $7,508.30 | 2025 | Artemis |
| Depuy Synthes Sales INC. | $1,295.96 | 2022 | |
| Arthrex, INC. | $662.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $197.66 | 2025 | Comprehensive Shoulder System |
| Peerless Surgical INC. | $147.36 | 2023 | |
| Treace Medical Concepts, INC. | $140.36 | 2025 | |
| Biotissue Holdings INC. | $124.71 | 2024 | |
| Medline Industries Lp | $57.71 | 2023 | |
| Crossroads Extremity Systems, LLC | $17.43 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.